{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:34:28Z","timestamp":1773178468807,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,9]]},"DOI":"10.7759\/cureus.104946","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:44:16Z","timestamp":1773110656000},"source":"Crossref","is-referenced-by-count":0,"title":["Moderate-Dose Local Radiotherapy in Symptomatic CD30-Positive, Anaplastic Lymphoma Kinase (ALK)-Negative Primary Cutaneous T-cell Lymphoma"],"prefix":"10.7759","author":[{"given":"Alejandra","family":"Varela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebasti\u00e1n","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole E","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael E","family":"Ara\u00faz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz M","family":"Champsaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"D Orcy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo","family":"Samudio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Primary cutaneous lymphomas. NCCN clinical practice guidelines in Oncology. (2025). Accessed: September 10, 2025: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/primary_cutaneous.pdf."},{"key":"ref2","unstructured":"T-Cell lymphoma. NCCN clinical practice guidelines Oncology. (2025). Accessed: September 11, 2025: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/t-cell.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115064","article-title":"Radiotherapy in cutaneous lymphomas: recommendations from the EORTC cutaneous lymphoma tumour group","volume":"212","author":"Elsayad K","year":"2024","unstructured":"Elsayad K, Guenova E, Assaf C, et al.. Radiotherapy in cutaneous lymphomas: recommendations from the EORTC cutaneous lymphoma tumour group. Eur J Cancer. 2024, 212:115064. 10.1016\/j.ejca.2024.115064","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.2018.001","article-title":"Cutaneous CD30-positive T-cell lymphoproliferative disorders - clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Kempf W","year":"2018","unstructured":"Kempf W, Kerl K, Mitteldorf C. Cutaneous CD30-positive T-cell lymphoproliferative disorders - clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018, 37:24-9. 10.12788\/j.sder.2018.001","journal-title":"Semin Cutan Med Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze R","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019, 133:1703-14. 10.1182\/blood-2018-11-881268","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy133","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Willemze R","year":"2018","unstructured":"Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018, 29:iv30-40. 10.1093\/annonc\/mdy133","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.03.023","article-title":"Radiation therapy for primary cutaneous anaplastic large cell lymphoma: an international lymphoma radiation oncology group multi-institutional experience","volume":"95","author":"Million L","year":"2016","unstructured":"Million L, Yi EJ, Wu F, et al.. Radiation therapy for primary cutaneous anaplastic large cell lymphoma: an international lymphoma radiation oncology group multi-institutional experience. Int J Radiat Oncol Biol Phys. 2016, 95:1454-9. 10.1016\/j.ijrobp.2016.03.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf W","year":"2011","unstructured":"Kempf W, Pfaltz K, Vermeer MH, et al.. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011, 118:4024-35. 10.1182\/blood-2011-05-351346","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16501","article-title":"Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group","volume":"179","author":"Melchers RC","year":"2018","unstructured":"Melchers RC, Willemze R, Bekkenk MW, et al.. Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group. Br J Dermatol. 2018, 179:724-31. 10.1111\/bjd.16501","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.08.010","article-title":"Recommendations for the optimal radiation dose in patients with primary cutaneous anaplastic large cell lymphoma: a report of the Dutch Cutaneous Lymphoma Group","volume":"99","author":"Melchers RC","year":"2017","unstructured":"Melchers RC, Willemze R, Dani\u00ebls LA, et al.. Recommendations for the optimal radiation dose in patients with primary cutaneous anaplastic large cell lymphoma: a report of the Dutch Cutaneous Lymphoma Group. Int J Radiat Oncol Biol Phys. 2017, 99:1279-85. 10.1016\/j.ijrobp.2017.08.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2017.06.004","article-title":"Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma","volume":"2","author":"Smith GL","year":"2017","unstructured":"Smith GL, Duvic M, Yehia ZA, et al.. Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma. Adv Radiat Oncol. 2017, 2:363-9. 10.1016\/j.adro.2017.06.004","journal-title":"Adv Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428512-moderate-dose-local-radiotherapy-in-symptomatic-cd30-positive-anaplastic-lymphoma-kinase-alk-negative-primary-cutaneous-t-cell-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:44:20Z","timestamp":1773110660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428512-moderate-dose-local-radiotherapy-in-symptomatic-cd30-positive-anaplastic-lymphoma-kinase-alk-negative-primary-cutaneous-t-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.104946","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}